Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenzhujing Pill for consumptive disease with qi and yin deficiency
ChiCTR2300074859Phase 4Recruiting
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Jul 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of shenzhujing in Tuberculosis (TB) (2 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoints: Fatigue scale and TCM syndrome score. Started Jul 2023; status: recruiting.
02
Drugs
shenzhujing
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2300074859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074859.